10 results
8-K
EX-3.2
SURF
Surface Oncology, Inc.
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:21am
, fees of expert witnesses, private investigators and professional advisors (including, without limitation, accountants and investment bankers
DEFM14A
SURF
Surface Oncology, Inc.
26 Jul 23
Proxy related to merger
4:56pm
as the Delaware Court of Chancery deems to be equitable under the circumstances. However, costs do not include attorneys and expert witness fees. Each stockholder … is responsible for its own attorneys and expert witnesses expenses, although, upon application of a stockholder, the Delaware Court of Chancery may
10-K/A
2022 FY
SURF
Surface Oncology, Inc.
1 May 23
Annual report (amended)
4:31pm
or Ethnicities
LGBTQ+
Middle Eastern
North African
Audit Committee and Audit Committee Financial Expert
Our Audit Committee is currently composed … and the applicable listing standards of Nasdaq. Our Board of Directors has determined that Ms. Stelzer is an “audit committee financial expert” within the meaning
8-K
EX-99.1
xhicd
12 Nov 19
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019
6:02am
DEF 14A
ag8yf3e 3ej7
19 Apr 19
Definitive proxy
6:04am
8-K
EX-3.2
aw4k91a4yej0qj2rn2
23 Apr 18
Unregistered Sales of Equity Securities
12:00am
424B4
9xwqawfrhn
20 Apr 18
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next